Evaluation of the Safety and Efficacy of REBORN System for Lipolysis Treatment
Clinical trial NCT05507528 · COMPLETED
Trial details
- NCT number
- NCT05507528
- Sponsor
- Lightfective Ltd
- Status
- COMPLETED
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2022-06-30
- Primary completion
- 2023-11-11
- Enrollment
- 107
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.